logo

Mereo Biopharma Group Plc ADR (MREO) Stock: A Comprehensive 52-Week Review

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Mereo Biopharma Group Plc ADR’s current trading price is -32.11% away from its 52-week high, while its distance from the 52-week low is 330.23%. The stock’s price range over this period has fluctuated between $0.69 and $4.36. The company, operating within the financial sector, had a trading volume of approximately 1.02 million for the day, which was noticeably lower than the average daily share volume of 1.74 million over the last 3 months.

In terms of market performance, Mereo Biopharma Group Plc ADR had a fairly even. The highest value for the stock in the past year was $4.36 on 02/05/24, and the lowest value was recorded at $0.69 on 03/29/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Mereo Biopharma Group Plc ADR (MREO) has experienced a quarterly rise of 41.63% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 380.03M and boasts a workforce of 36 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.83, with a change in price of +1.30. Similarly, Mereo Biopharma Group Plc ADR recorded 1,408,653 in trading volume during the last 100 days, posting a change of +78.31%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MREO stands at 0.16. Similarly, the long-term debt-to-equity ratio is also 0.08.

MREO Stock Stochastic Average

Today’s raw stochastic average for Mereo Biopharma Group Plc ADR over the last 50 days is 18.13%.This indicates a increase from the raw stochastic average of the past 20 days, which was 1.77%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 8.26% and 10.91%, respectively.

MREO Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price increase of 28.14%. However, over the past six months, we’ve seen a weaker performance of 109.93%. The price of MREO leaped by -16.38% over the last 30 days. And in the last five days, it has fallen by -5.73%.